Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - large image1
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image1
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image2
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image3
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image4
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image5
Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder buy - image6

Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder

COA 66 Inquiries

Unit Price: Get Latest Price
CAS No.:

1415456-99-3

Grade:

Pharmaceutical Grade

Content:

99%

Port:

香港

Brand:

HuiTu

Packaging:

5mg 10mg Vials

Price valid (until):

2026-07-01

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
3 days
Qualification:
Main Products:

Peptides,Retatrutide,GHK-CU

  • Product Details

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    We are a peptide manufacturer with our own research laboratory and production line. We are committed to producing high quality research grade peptides of exceptional purity and consistency. We ensure strict quality control at every stage. The production process of lyophilized powder is mainly based on vacuum freeze-drying. Vacuum freeze-drying is used to maximize the activity and stability of the active ingredient, and the entire process from preparation to freeze-drying is carried out in our manufacturing facility, ensuring strict quality control, purity and consistency of each batch. Our commitment to excellence extends from the initial stages of peptide synthesis to packaging and delivery. We implement stringent quality control measures at every step to ensure that our products reach our customers in the purest, most consistent form.
    Explore our range of products today and enhance your research


    Sales Manager: Lena
    WhatsApp: +44 7547 930159
    Email: 97925439lena@gmail.com


    Cagrelinide is a a cyclic peptide composed of 38 amino acids, with a sequence containing 38 amino acids and a pair of disulfide bonds. Kaglirin can significantly reduce weight and reduce food intake. Kagrelin peptide has potential in obesity research.
    As a non selective amino acid receptor (AMYR) and calcium G protein coupled receptor (CTR) advocate, Cagrinide is a new long acting acetylated amino acid analysis, which is a cyclic peptide composed of 38 amino acids The sequence contains a pair of defective bonds Cagritide can significantly reduce weight and food intake Cagritide has potential in objectivity research.

    Shop Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder-Detailed Image 1


    These products are active pharmaceutical ingredients (APIs), not finished pharmaceutical products.

    This product is for research and laboratory use only.

    The buyer must fully comply with all applicable laws and regulations regarding the handling and use of this material.


    Shop Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder-Detailed Image 2


    1. Ultra-high purity: Each batch of product undergoes synthesis and purification, achieving a purity of over 99% (HPLC), ensuring reliable and reproducible results in sensitive experiments.

    2. Precise dosage and consistency: Our peptide products are precisely weighed and vacuum-sealed under aseptic conditions. We strictly control batch-to-batch consistency.

    3. Endotoxin-free and aseptic processing: Our peptides are produced in a cleanroom environment, free from endotoxins, microbial contamination, and other impurities that could interfere with cellular or in vivo studies.


    Shop Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder-Detailed Image 3 Shop Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder-Detailed Image 4



    Why Choose Us?

    1. Factory direct sales, best prices, and best service.

    2. Safe and fast delivery.

    3. Supports various payment methods, including Alibaba, PayPal, bank transfer, etc.

    4. Ample inventory.

    5. Sincere service.

    6. Excellent reputation and positive customer reviews.

    7. Customers worldwide.


    Shop Cagrilintide | Made in China | 99% Purity | 5mg/10mg Vials | Freeze-dried Powder-Detailed Image 5
    Items Specifications
    Product Name Cagrelinide
    CAS No. 1415456-99-3
    Content  99%
    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Certificates

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides,Retatrutide,GHK-CU

    Location:

    Room 503, 5th Floor, Office Unit 501, New Triumphal Arch Health Products Mall, Changzheng Road, Chengguan Town, Taihe County, Fuyang City, Anhui Province

    Payment Terms:

    TT against copy of documents,D/P,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    3 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    51-100

    Year of Establishment:

    2026

  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    20 MG Sep 30, 2026
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    cagrilintide

    25 KG Sep 23, 2026
    Germany

    CAGRILINTIDE

    50 MG Sep 21, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    Australia

    Cagrilintide

    1 G Aug 25, 2026
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    10 MG Jul 13, 2026
    Peru

    Cagrilintide 20MG vial

    10 PCS Jul 10, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.